GLP-1 Eligibility: BMI and the U.S. Weight-Management Evaluation
Understand common adult BMI thresholds for weight-management medication, why eligibility is individualized, and what to prepare for a U.S. evaluation.
By Moukhtar Itani
Published
Updated

Quick answer: Common adult thresholds considered for weight-management medication are a BMI of at least 30, or at least 27 with a weight-related health condition. Meeting a threshold does not guarantee a GLP-1 prescription, insurance coverage or suitability for a specific product. A licensed clinician must review your health history and treatment needs.
Key takeaways
- Common adult screening thresholds are only the start of the evaluation.
- The exact product, indication, medical history and safety profile matter.
- Clinical suitability does not guarantee coverage, availability or a prescription.
What do the BMI thresholds mean?
The NIDDK medication overview describes these common adult thresholds. BMI uses height and weight as a screening measure. It is a starting point for clinical discussion, not a complete description of health or an automatic approval rule.
| Common adult screening situation | What happens next |
|---|---|
| BMI of 30 or greater | A clinician assesses whether medication is appropriate and which option fits |
| BMI of 27 or greater with a weight-related condition | The condition and product-specific requirements need review |
| A number outside these common thresholds | Discuss your health concern; do not assume a generic online rule determines every indication |
Children and adolescents have different assessment pathways. This article is for adults researching U.S. weight-management care, not a pediatric eligibility calculator.
GLP-1 eligibility depends on the exact medicine and use
Semaglutide and tirzepatide are active ingredients found in different branded products. Each product’s current label matters. The weight-management GLP-1 medication and weight-management dual-action GLP-1 medication labels also include defined uses beyond a general weight-management question.
Do not assume a diabetes diagnosis, sleep-apnea diagnosis or cardiovascular condition makes every product appropriate. Ask which indication is being considered and how it applies to your situation. Nor does the presence of an ingredient in two brands make their instructions identical.
What is reviewed beyond height and weight?
Expect a discussion of current conditions, medicines and supplements, previous treatment, pregnancy plans if relevant, family history and past reactions. Tell the clinician about symptoms or difficulties that could affect a plan, even if they seem unrelated to weight.
Important product contraindications and warnings need screening. For example, the branded products cited here have contraindications involving medullary thyroid carcinoma and MEN 2. This example is not a complete checklist, and passing a short online questionnaire is not proof that every risk has been ruled out.
What should you prepare for an online consultation?
- Your current height and weight, using the method requested by the provider.
- A list of medicines, supplements and relevant health conditions.
- Previous weight-management approaches and what was helpful or difficult.
- Relevant records or test results if the clinician requests them.
- Your goals, practical constraints and questions about follow-up.
Provide accurate information rather than trying to fit a threshold. If something is uncertain, say so. The purpose of the evaluation is to identify an appropriate plan, which may include a different option or further assessment.
Clinical eligibility, coverage and availability are separate questions
A clinician may judge that treatment is appropriate while an insurer applies different coverage requirements. An advertised price or savings program may also have separate terms. Ask for an explanation of each decision rather than treating them as one approval.
Likewise, the ability to access an online visit does not guarantee a specific medication, formulation or delivery option. Confirm the state in which you will receive care and the exact product being offered. Avoid a service that promises a prescription before meaningful assessment.
Where do compounded products fit?
The FDA’s GLP-1 guidance explains that compounded products are not FDA-approved and are not equivalent branded generics. A discussion about a compounded option needs its own clinical and product-specific rationale.
Do not view compounding as an automatic way around eligibility or an assurance that every route has the same evidence. Ask what is being proposed, why, and which uncertainties remain.
Use the visit to make an informed decision
Ask how benefits and tolerability will be reviewed, how to reach support and what alternatives are reasonable. You should understand the next step even if the answer is that medication is not appropriate today.
See FaroRx weight-management care and the semaglutide overview for background. A consultation supports evaluation; it does not guarantee treatment or coverage.
Explore FaroRx care and next steps
Start today — request a licensed-provider evaluation. A provider must assess suitability, alternatives and evidence. Completing an intake does not guarantee a prescription or benefit.
Related reading
Frequently asked questions
Does a BMI of 30 guarantee a GLP-1 prescription?
No. It is a common adult screening threshold, but clinical history, product-specific requirements, risks and treatment needs still require evaluation.
Can an adult with a BMI of 27 be considered?
Often the discussion involves a weight-related condition as well. A clinician must assess the individual situation and the proposed product.
Does medical eligibility guarantee insurance coverage?
No. Clinical suitability, insurer requirements, savings-program terms and product availability are separate questions.
Can compounded medication bypass the need for assessment?
No. Compounded treatment still requires an appropriate clinical evaluation and product-specific discussion. It is not an FDA-approved equivalent of a brand.
What should I bring to an online weight-management evaluation?
Prepare accurate height and weight information, your medication and health history, previous treatment experience, relevant records if requested, and your goals and questions.
Are adult BMI thresholds a pediatric eligibility rule?
No. Children and adolescents have different assessment pathways. This guide addresses adults researching U.S. weight-management care.
Sources
- NIDDK: prescription weight-management medications
- weight-management GLP-1 medication U.S. prescribing information
- weight-management dual-action GLP-1 medication U.S. prescribing information
- FDA GLP-1 guidance
Sources checked November 10, 2026. General education for U.S. adults; not individualized medical advice. Discuss treatment questions with a licensed healthcare professional.
This article is for general education only and is not medical advice. Compounded medications are not FDA-approved and are not generic versions of, or equivalent to, any branded medication. Prescribed only when clinically appropriate after an online medical visit.
Ready to see if you qualify?
Take a short online visit and a licensed provider will review your intake.
See if you qualify
